Filter
503
Text search:
nucleic
Acid
Featured
Recommendations
85
New Publications
133
Language
Document type
No document type
258
Guidelines
127
Studies & Reports
52
Manuals
37
Fact sheets
13
Strategic & Response Plan
5
Training Material
4
Infographics
3
Situation Updates
2
Resource Platforms
1
Videos
1
Countries / Regions
India
31
Western and Central Europe
17
Global
13
Africa
11
Eastern Europe
11
South Africa
7
Liberia
6
Ethiopia
6
Latin America and the Carribbean
6
Nigeria
5
Nepal
5
Tanzania
5
Rwanda
5
Brazil
5
Myanmar / Burma
5
East and Southern Africa
5
West and Central Africa
5
Ukraine
4
Angola
4
Eastern Europe and Central Asia
4
Asia
4
Russia
4
Sierra Leone
3
Congo, Democratic Republic of
3
Germany
3
Zambia
3
Bangladesh
3
Argentina
3
Namibia
3
Peru
3
Middle East and North Africa
3
Guinea
2
Senegal
2
Uganda
2
Philippines
2
Pakistan
2
Kenya
2
China
2
Mozambique
2
Vietnam
2
Portugal
2
Côte d’Ivoire / Ivory Coast
1
USA
1
Cameroon
1
South Sudan
1
Afghanistan
1
Turkey
1
Syria
1
Chad
1
Cambodia
1
Indonesia
1
Colombia
1
Botswana
1
El Salvador
1
Sri Lanka
1
South–East Asia Region
1
Bhutan
1
Timor Leste/ East Timor
1
Moldova
1
Georgia
1
France
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
109
Clinical Guidelines
95
Pharmacy & Technologies
32
Key Resources
13
Public Health
12
Women & Child Health
12
Capacity Building
2
Toolboxes
TB
102
COVID-19
86
HIV
65
Rapid Response
38
NTDs
24
Ebola
20
Zika
16
AMR
12
Refugee
11
Pharmacy
11
Polio
5
Planetary Health
4
Caregiver
3
Conflict
2
Natural Hazards
1
Specific Hazards
1
Global Health Education
1
Health Financing Toolbox
1
NCDs
1
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China.
19 March 2020
8 July 2020
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Because malaria cases are seen relatively rarely in North America, misdiagnosis by clinicians and laboratorians has been a commonly documented problem in published reports. However, malaria may be a common illness in areas where it is transmitted and therefore the diagnosis of malaria should routine
...
Prevention, identification and management of health worker infection in the context of COVID-19
recommended
This document provides interim guidance on the prevention, identification and management of health worker infection in the context of COVID-19. It is intended for occupational health departments, infection prevention and control departments or focal points, health facility administrators and public
...
Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19
recommended
ASLM in collaboration with the Africa Centres for Disease Control and Prevention, and in partnership with the Clinton Health Access Initiative, Amref and Last Mile Health present the Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19. This framework aims to pr
...
Summary of the Ethopian country office of WHO on COVID-19 activities.
This article is part four in a series of explainers on vaccine development and distribution.
Part one focused on how vaccines work to protect our bodies from disease-carrying germs.
Part two focused on the ingredients in a vaccine and the three clinical trial phases.
Part three focused on the ste
...
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic
...
22 July 2022. This document provides the case definitions for public health surveillance of COVID-19 in humans caused by SARS-COV-2 infection.
12 countries have a high TB estimated burden with an incidence rate more than 45 per 100 000 population They represent 88 of the cases in the Region
In 2019 the TB case detection gap in the Region was 52 500 cases
This policy guideIine is intended for use by healthcare professionals invoIved in the management of Covid-19 in South Africa. The document provides guidance on diagnostic tests available, on antigen test performance and accessibility. 1t focuses on key issues such as when to
Perform antigen tests
...
Technical specifications for selection of essential in vitro diagnostic tests for SARS-COV-2, 14 June 2021
